Ronald Hinklin is a medicinal chemist with over 22 years of experience in the pharmaceutical industry. They held several key leadership roles at Pfizer, serving as Associate Director and then as Senior Director of Medicinal Chemistry since 2021. Previously, they contributed significantly to drug development at Array BioPharma, leading projects on glucokinase activators and GPR119 agonists for diabetes, resulting in compounds that progressed to clinical trials. Ronald earned a PhD in Organic Chemistry from the University of Wisconsin-Madison and a Bachelor of Science in Biochemistry from Indiana University Bloomington.
This person is not in any teams
This person is not in any offices